|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.317
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.245
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.201
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.167
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.159
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.155
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.143
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.136
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.136
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.122
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.118
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.113
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.098
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.097
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.094
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.094
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.092
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.092
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.091
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.091
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.090
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.090
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.088
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.088
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.085
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.084
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.082
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.082
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.081
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.081
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.081
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.079
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.079
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.079
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.077
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.077
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.077
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.074
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.074
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.073
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.073
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.073
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.070
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.070
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.069
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.068
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.068
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.068
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.067
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.067
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.067
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.065
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.065
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.065
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.065
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.064
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.064
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.064
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.063
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.062
|
Mouse |
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.062
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.062
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.061
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.061
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.060
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.060
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.060
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.060
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.059
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.059
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.059
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.059
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.059
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.058
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.058
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.058
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.057
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.057
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.057
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.056
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.055
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.055
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.054
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.054
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.053
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.053
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.053
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.053
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.052
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.052
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.051
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.051
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.051
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.050
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.050
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.050
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.050
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.049
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.049
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.048
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.048
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.048
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.047
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.046
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.046
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.046
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.046
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.046
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.046
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.045
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.045
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.045
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.044
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.044
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.044
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.043
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.043
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.043
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.042
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.042
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.042
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.042
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.042
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.041
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.041
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.041
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.041
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.041
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.041
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.041
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.040
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.040
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.040
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.040
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.040
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.040
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.040
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.039
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.039
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.039
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.039
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.038
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.038
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.038
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.038
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.038
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.038
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.038
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.038
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.038
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.037
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.037
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.037
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.037
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.037
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.037
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.037
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.037
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.036
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.036
|
Mouse |
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.036
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.036
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.036
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.035
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.035
|
Mouse |
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.035
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.035
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.034
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.034
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.034
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.034
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.033
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.033
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.033
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.033
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.033
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.033
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.032
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.032
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.032
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.032
|
Mouse |
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.032
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.032
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.032
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.032
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.031
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.031
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.031
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.031
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.031
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.031
|
Mouse |
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.030
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.030
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.030
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.030
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.030
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.030
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.030
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.030
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.030
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.029
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.029
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.029
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.029
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.029
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.029
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.029
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.029
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.029
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.028
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.028
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.028
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.028
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.028
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.028
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.028
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.027
|
Mouse |
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.027
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.027
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.027
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.027
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.027
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.027
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.027
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.027
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.026
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.026
|
Mouse |
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.026
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.026
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.026
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.026
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.026
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.026
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.026
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.025
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.025
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.025
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.025
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.025
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.025
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.025
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.025
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.024
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.024
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.024
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.024
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.024
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.024
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.024
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.024
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.024
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.024
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.024
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.024
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.024
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.024
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.024
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.024
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.024
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.024
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.023
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.023
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.023
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.023
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.023
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.023
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.023
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.023
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.022
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.022
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.022
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.022
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.022
|
|
|
|
positive regulation of the force of heart contraction by epinephrine norepinephrine
|
GO:0001997 |
3 |
0.022
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.022
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.022
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.022
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.022
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.022
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.022
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.022
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.021
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.021
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.021
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.021
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.021
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.021
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.021
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.021
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.021
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.021
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.021
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.021
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.021
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.021
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.021
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.021
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.021
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.021
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.020
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.020
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.020
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.020
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.020
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.020
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.020
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.020
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.020
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.020
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.020
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.020
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.020
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.020
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.020
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.020
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.020
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.020
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.019
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.019
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.019
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.019
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.019
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.019
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.019
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.019
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.019
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.019
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.019
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.019
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.019
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.019
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.019
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.019
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.019
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.019
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.019
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.018
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.018
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.018
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.018
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.018
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.018
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.018
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.018
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.018
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.018
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.018
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.018
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.018
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.018
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.018
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.018
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.018
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.018
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.018
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.018
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.017
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.017
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.017
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.017
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.017
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.017
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.017
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.017
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.017
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.017
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.017
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.017
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.017
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.017
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.017
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.017
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.017
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.017
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.017
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.017
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.017
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.017
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.017
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.017
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.017
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
26 |
0.017
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.017
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.017
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.017
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.017
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.017
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.017
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.017
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.016
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.016
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.016
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.016
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.016
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.016
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.016
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.016
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.016
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.016
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.016
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.016
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.016
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.016
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.016
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.016
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.016
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.016
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.016
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.016
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.016
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.016
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.016
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.016
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.016
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.016
|
Mouse |
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.016
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.016
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.016
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.016
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.016
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.016
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.015
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.015
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.015
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.015
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.015
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.015
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.015
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.015
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.015
|
Mouse |
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.015
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.015
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.015
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.015
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.015
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.015
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.015
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.015
|
|
|
|
negative regulation of fibroblast growth factor production
|
GO:0090272 |
2 |
0.015
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.015
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.015
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.015
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.015
|
|
|
|
response to inactivity
|
GO:0014854 |
4 |
0.015
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.015
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.015
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.015
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.015
|
|
|
|
sensitization
|
GO:0046960 |
2 |
0.015
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.015
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.015
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.015
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.015
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.015
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.015
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.015
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.015
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.015
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.015
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.015
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.015
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.015
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.014
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.014
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.014
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.014
|
|
|
|
regulation of neurological system process
|
GO:0031644 |
22 |
0.014
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.014
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.014
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.014
|
Mouse |
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.014
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.014
|
Mouse |
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.014
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.014
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.014
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.014
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.014
|
|
|
|
synaptic transmission glutamatergic
|
GO:0035249 |
36 |
0.014
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.014
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.014
|
|
|
|
cellular response to epidermal growth factor stimulus
|
GO:0071364 |
4 |
0.014
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.014
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.014
|
|
|
|
regulation of ovulation
|
GO:0060278 |
3 |
0.014
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.014
|
Mouse |
|
|
inflammatory response
|
GO:0006954 |
244 |
0.014
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.014
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.014
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.014
|
Mouse |
|
|
olfactory bulb axon guidance
|
GO:0071678 |
1 |
0.014
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.014
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.014
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.014
|
|
